{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 AST-Gram Negative Tobramycin",
        "VITEK\u00ae 2 AST-GN Tobramycin"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K163083",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113200"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTW",
        "LTT"
    ],
    "Summary Letter Date": "October 27, 2016",
    "Summary Letter Received Date": "November 3, 2016",
    "Submission Date": "October 27, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Tobramycin"
    ],
    "Specimen Type(s)": [
        "Isolated colonies of Gram negative bacilli"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2",
        "VITEK\u00ae 2 Compact Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Antimicrobial susceptibility testing",
        "Broth microdilution",
        "Minimum inhibitory concentration (MIC) microdilution"
    ],
    "Methodologies": [
        "Automated antimicrobial susceptibility testing",
        "Microdilution methodology"
    ],
    "Submission Type(s)": [
        "Assay",
        "Card",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-GN Tobramycin antimicrobial susceptibility test for Gram negative bacilli using automated microdilution methodology",
    "Indications for Use Summary": "Designed for antimicrobial susceptibility testing of Gram negative bacilli to tobramycin as a qualitative test on VITEK 2 and VITEK 2 Compact Systems, aiding determination of in vitro susceptibility to antimicrobial agents",
    "fda_folder": "Microbiology"
}